{{Rsnum
|rsid=4844880
|Gene=HSD11B1
|Chromosome=1
|position=209697571
|Orientation=plus
|GMAF=0.3549
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=HSD11B1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 1.8 | 28.6 | 69.6
| HCB | 23.4 | 45.3 | 31.4
| JPT | 30.1 | 55.8 | 14.2
| YRI | 39.7 | 46.6 | 13.7
| ASW | 24.6 | 56.1 | 19.3
| CHB | 23.4 | 45.3 | 31.4
| CHD | 18.5 | 48.1 | 33.3
| GIH | 15.8 | 28.7 | 55.4
| LWK | 41.8 | 44.5 | 13.6
| MEX | 0.0 | 32.8 | 67.2
| MKK | 21.8 | 51.9 | 26.3
| TSI | 1.0 | 25.5 | 73.5
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19388848
|Title=Association among IRF6 polymorphism, environmental factors, and nonsyndromic orofacial clefts in western china
}}

{{PMID Auto
|PMID=18278815
|Title=Genetic variants in IRF6 and the risk of facial clefts: single-marker and haplotype-based analyses in a population-based case-control study of facial clefts in Norway.
|OA=1
}}

{{PMID Auto
|PMID=22986073
|Title=The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
}}

{{PMID Auto
|PMID=24976539
|Title=NNK reduction pathway gene polymorphisms and risk of lung cancer
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}